日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pancreatic volume and immune biomarkers predict checkpoint inhibitor-associated autoimmune diabetes in humans

胰腺体积和免疫生物标志物可预测人类免疫检查点抑制剂相关的自身免疫性糖尿病

Wu, Linda; Wentworth, John M; Liddle, Christopher; Fewings, Nicole; Carlino, Matteo; Brown, David A; Clifton-Bligh, Roderick; Long, Georgina V; Scolyer, Richard A; Norris, Nicholas; Sasson, Sarah C; Tsang, Venessa Hm; Menzies, Alexander M; Gunton, Jenny E

GLUT1 expression, lymphocyte distribution and CD3(+) T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma

GLUT1表达、淋巴细胞分布和CD3(+) T细胞代谢亚群作为晚期黑色素瘤免疫治疗反应的预测标志物

Paver, Elizabeth C; Gide, Tuba N; Yaseen, Zarwa; Cornejo-Paramo, Paola; Ferguson, Peter; Maher, Nigel G; Menzies, Alexander M; Carlino, Matteo S; da Silva, Ines Pires; Holst, Jeff; Long, Georgina V; Scolyer, Richard A; Wilmott, James S

Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial

帕博利珠单抗辅助治疗IIB期或IIC期黑色素瘤:一项随机临床试验的二次分析

Leachman, Sancy A; Luke, Jason J; Ascierto, Paolo A; Long, Georgina V; Khattak, Muhammad A; Rutkowski, Piotr; Xu, Zhi Jin; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M M; Schadendorf, Dirk

Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma

前瞻性肿瘤突变负荷和新抗原谱分析可预测转移性黑色素瘤的免疫治疗反应

Mao, Yizhe; Gide, Tuba N; Maher, Nigel G; Vignati, Danielle; Boutros, Andrea; Cornejo-Páramo, Paola; Potter, Alison J; Carlino, Matteo S; Paver, Elizabeth C; Burke, Hazel; Menzies, Alexander M; Lo, Serigne N; da Silva, Inês Pires; Scolyer, Richard A; Long, Georgina V; Vergara, Ismael A; Wilmott, James S

Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma

泼尼松龙通过调节 CD8⁺ 和调节性 T 细胞的活性来减弱黑色素瘤对免疫检查点抑制剂疗法的反应。

Brown, Jesse R; Pedersen, Bernadette; Long, Georgina V; Maher, Nigel G; Lim, Su Yin; Rizos, Helen; Shklovskaya, Elena

International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma

关于新辅助全身治疗后III期黑色素瘤患者行索引淋巴结手术的证据的国际调查

Novis, Elan; Rautalin, Mervi; Amaria, Rodabe N; Ascierto, Paolo A; Blank, Christian U; Faries, Mark B; Grunhagen, Dirk J; Gyorki, David E; Hayes, Andrew J; Kuijpers, Anke M J; Long, Georgina V; Mammen, Joshua M V; Menzies, Alexander M; Ross, Merrick I; Rutkowski, Piotr; Tawbi, Hussein A; Tetzlaff, Michael T; Zager, Jonathan S; Wargo, Jennifer A; Hieken, Tina J; van Akkooi, Alexander C J

The Prognostic Significance of Tumoral Melanosis

肿瘤性黑变病的预后意义

Potter, Alison J; Ferguson, Peter M; Lo, Serigne N; Ahmed, Tasnia; Rawson, Robert V; Thompson, John F; Long, Georgina V; Scolyer, Richard A

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

晚期黑色素瘤患者接受纳武利尤单抗联合伊匹木单抗治疗的最终10年疗效

Wolchok, Jedd D; Chiarion-Sileni, Vanna; Rutkowski, Piotr; Cowey, C Lance; Schadendorf, Dirk; Wagstaff, John; Queirolo, Paola; Dummer, Reinhard; Butler, Marcus O; Hill, Andrew G; Postow, Michael A; Gaudy-Marqueste, Caroline; Medina, Theresa; Lao, Christopher D; Walker, John; Márquez-Rodas, Iván; Haanen, John B A G; Guidoboni, Massimo; Maio, Michele; Schöffski, Patrick; Carlino, Matteo S; Sandhu, Shahneen; Lebbé, Céleste; Ascierto, Paolo A; Long, Georgina V; Ritchings, Corey; Nassar, Ayman; Askelson, Margarita; Benito, Melanie Pe; Wang, Wenjia; Hodi, F Stephen; Larkin, James

Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trial

新辅助抗PD-1单药治疗或联合抗TIGIT或溶瘤病毒治疗可切除的IIIB-D期黑色素瘤:一项1/2期试验

Dummer, Reinhard; Robert, Caroline; Scolyer, Richard A; Taube, Janis M; Tetzlaff, Michael T; Menzies, Alexander M; Hill, Andrew; Grob, Jean-Jacques; Portnoy, David C; Lebbe, Celeste; Khattak, Muhammad A; Cohen, Jonathan; Bar-Sela, Gil; Mehmi, Inderjit; Shapira-Frommer, Ronnie; Meyer, Nicolas; Webber, Andrea L; Ren, Yixin; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Long, Georgina V

Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial

可切除黑色素瘤新辅助治疗中,PD-1 和 LAG-3 靶向双特异性抗体与其他免疫检查点抑制剂联合疗法:一项随机 1b/2 期 Morpheus-Melanoma 试验

Long, Georgina V; Nair, Nitya; Marbach, Daniel; Scolyer, Richard A; Wilson, Sabine; Cotting, Denise; Staedler, Nicolas; Amaria, Rodabe N; Ascierto, Paolo Antonio; Tarhini, Ahmad A; Robert, Caroline; Hamid, Omid; Gaudy-Marqueste, Caroline; Lebbe, Celeste; Munoz-Couselo, Eva; Menzies, Alexander M; Pages, Cecile; Curigliano, Giuseppe; Mandala, Mario; Jessop, Nikki; Bader, Uwe; Perdicchio, Maurizio; Teichgräber, Volker; Muecke, Merlind; Markert, Christoph; Blank, Christian